Cargando…

Metronomic oral paclitaxel shows anti-tumor effects in an orthotopic mouse model of ovarian cancer

OBJECTIVE: The purpose of this study was to compare the in vivo anti-tumor efficacy of a mucoadhesive, lipid-based, oral paclitaxel formulation (DHP107) with traditional, intraperitoneal (IP) paclitaxel using an orthotopic mouse model of chemotherapy-sensitive SKOV3ip1 ovarian cancer. METHODS: To de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hahn, Ho-Suap, Lee, Ki-Heon, Lee, In-Ho, Lee, Jae-Ho, Whang, Chang-Sung, Jo, Yeong-Woo, Kim, Tae-Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996263/ https://www.ncbi.nlm.nih.gov/pubmed/24761217 http://dx.doi.org/10.3802/jgo.2014.25.2.130

Ejemplares similares

Selective cyclooxygenase inhibitors increase paclitaxel sensitivity in taxane-resistant ovarian cancer by suppressing P-glycoprotein expression
por: Lee, Jung-Pil, et al.
Publicado: (2013)

Comparison of laparoscopy and laparotomy for the management of early-stage ovarian cancer: surgical and oncological outcomes
por: Koo, Yu-Jin, et al.
Publicado: (2014)

The safety of conization in the management of adenocarcinoma in situ of the uterine cervix
por: Kim, Mi-La, et al.
Publicado: (2011)

Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer
por: Pujade-Lauraine, Eric
Publicado: (2013)

Establishment of linear accelerator-based image guided radiotherapy for orthotopic 4T1 mouse mammary tumor model
por: Lee, Seung-Heon, et al.
Publicado: (2014)

Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients
por: Jung, Yun Hwa, et al.
Publicado: (2017)

Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin
por: Dessai, S. B., et al.
Publicado: (2016)

Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer
por: Noronha, Vanita, et al.
Publicado: (2016)

Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models
por: Hackl, Christina, et al.
Publicado: (2013)

Establishment of an Orthotopic Mouse Non-Muscle Invasive Bladder Cancer Model Expressing the Mammalian Target of Rapamycin Signaling Pathway
por: Kim, Soon-Ja, et al.
Publicado: (2014)

Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer
por: Huang, Wen-Yen, et al.
Publicado: (2017)

Oral metronomic chemotherapy for recurrent & refractory epithelial ovarian cancer: A retrospective analysis
por: Sharma, Aparna, et al.
Publicado: (2019)

Coronary Artery Thrombosis Associated With Paclitaxel in Advanced Ovarian Cancer
por: Park, Sang-Ho, et al.
Publicado: (2009)

Metronomic Gemcitabine in Combination with Sunitinib Inhibits Multisite Metastasis and Increases Survival in an Orthotopic Model of Pancreatic Cancer
por: Tran Cao, Hop S., et al.
Publicado: (2010)

Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer
por: Khan, Kabir A., et al.
Publicado: (2020)

Antiangiogenic Therapy with Human Apolipoprotein(a) Kringle V and Paclitaxel in a Human Ovarian Cancer Mouse Model()()
por: Yu, Hyun-Kyung, et al.
Publicado: (2014)

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
por: Pannier, Diane, et al.
Publicado: (2018)

Metronomic Therapy in Oral Squamous Cell Carcinoma
por: Su, Nai-Wen, et al.
Publicado: (2021)

Oral Cancer Surgery and COVID pandemic – Metronomic Therapy shows a promising role while awaiting surgery
por: Sultania, Mahesh, et al.
Publicado: (2020)

Erratum: Correction of Acknowledgement. Establishment of an Orthotopic Mouse Non-Muscle Invasive Bladder Cancer Model Expressing the Mammalian Target of Rapamycin Signaling Pathway
por: Kim, Soon-Ja, et al.
Publicado: (2014)

Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy
por: Maharjan, Ruby, et al.
Publicado: (2019)

The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer
por: Barber, Emma L., et al.
Publicado: (2013)

Effectiveness and toxicity of metronomic oral cyclophosphamide for recurrent or platinum-refractory ovarian cancer: A meta-analysis
por: Huang, Lili, et al.
Publicado: (2022)

Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC)
por: Kashyap1, Lakhan, et al.
Publicado: (2021)

Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
por: Perroud, Herman Andrés, et al.
Publicado: (2017)

Development of a Novel Orthotopic Gastric Cancer Mouse Model
por: Kang, Wonyoung, et al.
Publicado: (2021)

Metronomic and single high-dose paclitaxel treatments produce distinct heterogenous chemoresistant cancer cell populations
por: Mejia Peña, Carolina, et al.
Publicado: (2023)

Metronomic chemotherapy
por: Maiti, Rituparna
Publicado: (2014)

Metronomic Chemotherapy
por: Cazzaniga, Marina Elena, et al.
Publicado: (2021)

P70S6K and Elf4E Dual Inhibition Is Essential to Control Bladder Tumor Growth and Progression in Orthotopic Mouse Non-muscle Invasive Bladder Tumor Model
por: Chi, Byung Hoon, et al.
Publicado: (2015)

Ovarian Cancer during Pregnancy: Clinical and Pregnancy Outcome
por: Kwon, Yong-Soon, et al.
Publicado: (2010)

Therapeutic effiacy of T cells expressing chimeric antigen receptor derived from a mesothelin-specific scFv in orthotopic human pancreatic cancer animal models
por: Lee, Hyeon Ho, et al.
Publicado: (2021)

Correction to: Development of a Novel Orthotopic Gastric Cancer Mouse Model
por: Kang, Wonyoung, et al.
Publicado: (2021)

Long-term Mortality in Adult Orthotopic Heart Transplant Recipients
por: Jung, Sung-Ho, et al.
Publicado: (2011)

Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma
por: Lee, Victor H.F., et al.
Publicado: (2017)

Tumor Establishment Features of Orthotopic Murine Bladder Cancer Models
por: Lee, Jin Seok, et al.
Publicado: (2012)

Metronomic Chemotherapy for Palliative Treatment of Malignant Oral Tumors in Dogs
por: Milevoj, Nina, et al.
Publicado: (2022)

Acid-base disorders after orthotopic bladder replacement: comparison of an ileal neobladder and an ileal conduit
por: Cho, AJin, et al.
Publicado: (2017)

Cutaneous Plasmacytosis Showing a Neuronal Involvement in a 35-Year-Old Female
por: Suh, Joong-Heon, et al.
Publicado: (2020)

Immunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast cancer
por: Foy, Kevin C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vhs0tpitv17hab0t47jrt87vqk